NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

ex
we have been over this a few times.

This happens to be my field of expertise and from your post, I can tell your legal knowledge has a beginning and an end. You are NO legal expert.

Again:
A failed medical trial, especially in the case of NWBO since it's their only trial, will force NWBO a major deduction of its financial asset. They have spent near $ 1 billion into the trials can be considered as sunk cost. It doesn't matter its only partially om their balance sheet.

Not to mention that in that case, NWBO is technically bankrupt if you understand what bankruptcy is for a biotech company.

Therefore you are absolutely completely wrong on this. The moment NWBO has come to the conclusion they will not be able to market DCVAX-L is the moment they will have to 8-K that fact as Material Impairments. Also because their future predicted revenue has crashed. I suggest you read this


Predictable Materiality: A Need for Common Criteria Governing
the Disclosur the Disclosure of Clinical T e of Clinical Trial Results b rial Results by Publicity-T y Publicity-Traded
Pharmaceutical Companies
https://scholarship.law.edu/cgi/viewcontent.cgi?article=1016&context=jchlp

https://www.arnoldporter.com/en/perspectives/publications/2013/06/predictable-materiality-a-need-for-common-criter__

I have back and forward. I have studies multi verdicts on the subject. Have you?